In comparison to the “Sham IR + ICI” group, a significant increase in the absolute number of tumor-infiltrating immune cells (CD45+) in the tumors of mice treated with “TM IR + ICI” was observed already on day 2 after IR (Supplementary Fig. 1B). This evidence concerns the gene PTPRC and neoplasm.